Praxis Technology (also known as Praxis Powder Technology) is a manufacturing company specializing in high-performance titanium parts produced via powder metallurgy and titanium metal injection molding (TiMIM).[4][5] It serves industries including medical, aerospace, automotive, and consumer products, solving challenges in creating complex, porous titanium components that meet stringent regulatory standards like FDA registration and ISO-13485 certification.[4][5] The company focuses on proprietary processes for demanding applications, enabling collaboration from product development to regulatory submissions, with a Device Master File submitted to the FDA in 2016 for its Ti-6Al-4V material.[5]
Headquartered in Queensbury, New York, Praxis operates with around 26 employees and generates approximately $10.7 million in revenue, having raised under $5 million across two funding rounds.[4] Its growth emphasizes high-quality titanium solutions, particularly porous parts, positioning it as a niche player in advanced materials manufacturing.[4][5]
Praxis Technology emerged as a specialized manufacturer in the titanium powder metallurgy space, with its website and profiles indicating a focus refined over years to target high-performance applications.[5] While exact founding details are not specified in available sources, the company has established itself through proprietary process development, culminating in key milestones like FDA Device Master File submission in 2016 and ISO-13485 certification.[4][5] Early traction likely stemmed from addressing needs in regulated sectors, building a track record in TiMIM and porous titanium for medical and aerospace uses, which demand precision and compliance.[4][5]
Praxis Technology rides the trend of advanced materials in additive and precision manufacturing, particularly for titanium in high-stakes industries like aerospace and medical devices where lightweight, biocompatible parts are critical.[4][5] Timing aligns with rising demand for porous titanium in implants and structural components, driven by market forces such as regulatory pressures, supply chain localization, and innovation in hybrid manufacturing.[4][5] It influences the ecosystem by enabling faster regulatory paths for clients via its master file and processes, supporting broader adoption of TiMIM in scaling production for electric vehicles, implants, and defense applications.[4][5]
Praxis is poised to expand as titanium demand surges in medtech (e.g., orthopedic implants) and aerospace (e.g., lightweight alloys), fueled by trends like 3D printing integration and sustainable manufacturing.[4][5] Expect growth through partnerships leveraging its regulatory edge, potentially increasing funding or acquisitions to scale capacity amid employee growth trajectories.[4] Its influence may evolve by standardizing TiMIM for emerging sectors like EVs, solidifying its role from niche supplier to key enabler in high-performance materials—echoing its core strength in turning complex titanium challenges into compliant, scalable realities.[4][5]
Praxis has raised $4.0M in total across 1 funding round.
Praxis's investors include ARCH Venture Partners, Byers Capital, Craft Ventures, Founders Fund, Paradigm, Ken Howery, Sam Altman.
Praxis has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in November 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2021 | $4.0M Seed | ARCH Venture Partners, Byers Capital, Craft Ventures, Founders Fund, Paradigm, Ken Howery, Sam Altman |
